Gracell Biotechnologies Inc. ADR (GRCL)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Wei Cao
Employees:
350
BUILDING 3, 418 GUILIN ROAD, XUHUI DISTRICT, SHANGHAI, CHINA 200030
00862164031522

Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, discovers and develops cell therapies for the treatment of cancer in the People's Republic of China. Its lead product candidates include GC012F, a FasTCAR-enabled dual BCMA- and CD19-directed autologous CAR-T product candidate. GC019F is in Phase I clinical trial for the. treatment of adult B cell acute lymphoblastic leukemia (B-ALL)

Data derived from most recent annual or quarterly report
Market Cap 392.462 Million Shares Outstanding72.678 Million Avg 30-day Volume 483.52 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.26
Price to Revenue0.0 Debt to Equity0.1202 EBITDA-79.331 Million
Price to Book Value3.9013 Operating Margin0.0 Enterprise Value590.753 Million
Current Ratio6.779 EPS Growth0.812 Quick Ratio6.609
1 Yr BETA 1.8731 52-week High/Low 6.99 / 1.4 Profit Margin0.0
Operating Cash Flow Growth-46.4252 Free Cash Flow to Firm (FCFF) TTM -54.653 Million Free Cash Flow to Equity (FCFE) TTM-45.319 Million
Altman Z-Score9.7859
View SEC Filings from GRCL instead.

Funds Holding GRCL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GRCL

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
GRACELL BIOTECHNOLOGIES-ADR GRCL 2023-11-28 22:15:04 UTC 3.6756 1.6444 3900000
GRACELL BIOTECHNOLOGIES-ADR GRCL 2023-11-28 21:45:03 UTC 3.6756 1.6444 3900000
GRACELL BIOTECHNOLOGIES-ADR GRCL 2023-11-28 21:15:04 UTC 3.6756 1.6444 3900000
GRACELL BIOTECHNOLOGIES-ADR GRCL 2023-11-28 20:45:04 UTC 3.6756 1.6444 3900000
GRACELL BIOTECHNOLOGIES-ADR GRCL 2023-11-28 20:15:04 UTC 3.6756 1.6444 3900000
GRACELL BIOTECHNOLOGIES-ADR GRCL 2023-11-28 19:45:03 UTC 3.6756 1.6444 3900000
GRACELL BIOTECHNOLOGIES-ADR GRCL 2023-11-28 19:15:04 UTC 3.6756 1.6444 3900000
GRACELL BIOTECHNOLOGIES-ADR GRCL 2023-11-28 18:45:03 UTC 3.6756 1.6444 3900000
GRACELL BIOTECHNOLOGIES-ADR GRCL 2023-11-28 18:15:03 UTC 3.6756 1.6444 3900000
GRACELL BIOTECHNOLOGIES-ADR GRCL 2023-11-28 17:45:04 UTC 3.7391 1.5809 3900000
GRACELL BIOTECHNOLOGIES-ADR GRCL 2023-11-28 17:15:04 UTC 3.7391 1.5809 4000000
GRACELL BIOTECHNOLOGIES-ADR GRCL 2023-11-28 16:45:04 UTC 3.7391 1.5809 4000000
GRACELL BIOTECHNOLOGIES-ADR GRCL 2023-11-28 16:15:04 UTC 3.7391 1.5809 3900000
GRACELL BIOTECHNOLOGIES-ADR GRCL 2023-11-28 15:45:03 UTC 3.7428 1.5772 3900000
GRACELL BIOTECHNOLOGIES-ADR GRCL 2023-11-28 15:15:03 UTC 3.7428 1.5772 3900000
GRACELL BIOTECHNOLOGIES-ADR GRCL 2023-11-28 14:45:04 UTC 3.7411 1.5789 3900000
GRACELL BIOTECHNOLOGIES-ADR GRCL 2023-11-28 14:15:04 UTC 3.7411 1.5789 3900000
GRACELL BIOTECHNOLOGIES-ADR GRCL 2023-11-28 13:45:04 UTC 3.7075 1.6125 3000000
GRACELL BIOTECHNOLOGIES-ADR GRCL 2023-11-28 13:15:03 UTC 3.7075 1.6125 3000000
GRACELL BIOTECHNOLOGIES-ADR GRCL 2023-11-28 12:45:04 UTC 3.7075 1.6125 3000000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

WhaleWisdom Logo

Elevate your investments